Just when everyone was still sick, A-shares ushered in good news. Shanghai issued the "Shanghai Action Plan to Support the Merger and Reorganization of Listed Companies (2025-2027)". Is this to retain injured retail investors? Next, let's discuss it in detail.It is worth noting that the action plan ranks biomedicine in the second place, and sets up a 10 billion biomedical industry M&A fund, which is basically the same as the status of integrated circuits. In addition, the action plan puts the merger of securities companies at the end, and its status has declined.The action plan can be called a heavy release in Shanghai, and I will simply classify the main contents.
First, Tuesday's market rally was really disgusting to everyone, but the good thing was to cover the gap of the day's upward gap and rule out the hidden danger of covering the gap in the market outlook.Second, the key areas mainly involve integrated circuits, biomedicine, new materials and other industries. Make good use of the 10 billion yuan integrated circuit design industry M&A fund and set up a 10 billion yuan biomedical industry M&A fund;In the end, the A-share market has ushered in a positive trend. However, investors were like frightened birds after Tuesday's A-share surge and fall. They were already afraid of good news and didn't know whether to leave or stay. Personally, as long as the trend of A shares does not go bad, I will choose to stay.
The action plan can be called a heavy release in Shanghai, and I will simply classify the main contents.Third, cultivate about 10 internationally competitive listed companies in the field;It is worth noting that the action plan ranks biomedicine in the second place, and sets up a 10 billion biomedical industry M&A fund, which is basically the same as the status of integrated circuits. In addition, the action plan puts the merger of securities companies at the end, and its status has declined.
Strategy guide
12-13
Strategy guide 12-13